NCT06629532

Brief Summary

The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
285mo left

Started Oct 2024

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Oct 2024Oct 2049

First Submitted

Initial submission to the registry

October 3, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
20 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2044

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2049

Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

20 years

First QC Date

October 3, 2024

Last Update Submit

October 3, 2024

Conditions

Intracerebral Hemorrhage

Keywords

intracerebral hemorrhageOutcomeManagementSurgical interventionsReal-worldDisparitiesMulticentric data

Outcome Measures

Primary Outcomes (1)

  • modified Rankin Score (mRS)

    0=no symptoms, 1=no significant disability, 2=slight disability, 3= moderate disability, 4=moderate severe disability, 5=severe disability, 6=death

    at least 6 months

Interventions

medical management, surgical interventions, and rehabilitative strategiesOTHER

By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cerebral hemorrhage from various causes

You may qualify if:

  • Cerebral hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cerebral Hemorrhage

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Tao Liu, MD

CONTACT

61-466068193TLiu1@georgeinstitute.org.au

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 3, 2024

First Posted

October 8, 2024

Study Start

October 15, 2024

Primary Completion (Estimated)

October 15, 2044

Study Completion (Estimated)

October 15, 2049

Last Updated

October 8, 2024

Record last verified: 2024-10